What's Happening?
Parse Biosciences has expanded its Certified Service Provider (CSP) Program by partnering with Single Cell Discoveries, a Netherlands-based contract research organization. This partnership aims to enhance access to Parse's single cell sequencing technology across Europe and globally. Single Cell Discoveries specializes in single-cell sequencing, spatial transcriptomics, and multiomic applications, and will now offer Parse's scalable technology to support researchers in drug discovery and innovation. The CSP Program connects researchers with vetted partners to outsource single cell projects, ensuring high-quality data and service standards.
Why It's Important?
The expansion of Parse Biosciences' CSP Program is significant for the scientific community, as it provides researchers with reliable access to advanced single cell sequencing technology. This partnership can accelerate scientific discoveries by offering scalable and high-quality analysis, which is essential for research in areas like cancer treatment, tissue repair, and stem cell therapy. By collaborating with Single Cell Discoveries, Parse Biosciences strengthens its presence in Europe, potentially driving innovation and facilitating breakthroughs in biopharmaceutical research. This move also highlights the importance of partnerships in advancing scientific research and technology.
